Fingerprint
Dive into the research topics of 'Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis
Kim Papp*, Kenneth Gordon, Diamant Thaçi, Akimichi Morita, Melinda Gooderham, Peter Foley, Ihab G. Girgis, Sudeep Kundu, Subhashis Banerjee
*Corresponding author for this work
66
Citations
(Scopus)